"Prognostic value of 18 F-FDG PET/CT radiomics for survival and recurrence in non–small cell lung cancer: a systematic review of 3,180 patients" Elhaie, M., Koozari, A. & Abedi, I. rdcu.be/eOOrU link.springer.com/article/10.100…

"Leading the theranostic revolution: addressing the recruitment crisis in European nuclear medicine" Perera Molligoda Arachchige, A.S. rdcu.be/eOOr9 link.springer.com/article/10.100…

"From 2015 to 2025: how ATA guidelines reshape nuclear medicine practice in thyroid cancer" Albano, D., Rizzo, A. rdcu.be/eOOn5 link.springer.com/article/10.100…

"Navigating the safety profile of Actinium-225 targeted alpha therapy: a comprehensive review" Roustaei, H., D’Alessandria, C. & Decristoforo, C. rdcu.be/eOOo7 link.springer.com/article/10.100…

"Ma, L., Li, X., Quan, Z. et al. Clinical study on bile excretion pattern of [18F]AlF-FAPI-74 and measures to eliminate its physiological uptake in the hepatobiliary system." rdcu.be/eSl4M link.springer.com/article/10.100…

"Lin, Y., Wang, T., Zhang, Y. et al. Evaluating the diagnostic performance of 18F-FDG PET/CT in primary cutaneous lymphoma: improving diagnostic accuracy for nodal staging." rdcu.be/eSl5J link.springer.com/article/10.100…

"Kabunda, J., Ndlovu, H., Chimbabantu, K. et al. Ethical dilemmas and medicolegal implications of nuclear medicine imaging in dementias." rdcu.be/eSl5Q link.springer.com/article/10.100…

One of the biggest questions in prostate cancer research is how to best leverage PSMA PET in clinical trials. Hear from Dr. Alicia Morgans as she explores how PSMA PET can be integrated as a clinical trial endpoint.

"Comparison of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for staging of the axillary lymph nodes in breast cancer patients" Kalender E., Ekinci Yıldırım E., Mumcu Çimen V. et al. link.springer.com/article/10.100…

"18F-FDG PET/CT: bicuspid aortic valve patients’ underestimated ally. A systematic review" Triumbari E.K.A., Casciani E., Guarneri A. et al. link.springer.com/article/10.100…

"Joint survey by AIMN, AIOM, AIRO, SIU, SIUrO, and Meet-URO about the use of PSMA PET imaging in prostate cancer in Italy: technical aspects and primary staging setting" Bauckneht M., Evangelista L., Sofia L. et al. rdcu.be/eWJOT link.springer.com/article/10.100…

"Real-world, multicenter assessment of 18F-FDG PET/CT prognostic value in triple-negative breast cancer (TRINE-PET): the study protocol" Urso L., Panareo S., Iudicello A. et al. rdcu.be/eWJSm link.springer.com/article/10.100…

"Living longer, living better: PSMA-PET insights" Spadafora, M., Guglielmo, P., Facchini, G. et al. rdcu.be/e1t9T link.springer.com/article/10.100…

"Diagnostic performance of a machine learning approach applied to delayed [18F]florbetaben positron emission tomography in patients with suspected light-chain cardiac amyloidosis" Giorgetti, A., Santarelli, M.F., Genovesi, D. et al. rdcu.be/e1t9U

Call for Mentors 📣 Following the success of the first edition, we are pleased to open the Call for Mentors for the next EANM Mentorship Programme. Support early career professionals and help shape the future of #NuclearMedicine. Apply by March 15 🔗eanm.org/the-eanm-commu…

New prostate cancer risk groups by PSMA-PET (PPP3): an international, retrospective, registry-based cohort study thelancet.com/journals/lanon… In an international registry study of 11,154 patients, investigators developed PPP3 nomograms integrating clinical features and PSMA-PET

🚨 Gamechanger #PRIMARY2 RCT #EAU26, presented and in press The Lancet Oncology. PSMA-PET CT in men with equivocal or -ve MRI but red flags results reduces biopsy by 49% and has non-inferior csPCa detection to template biopsy in all. Proud to be part of this🚨

"SPECT-based radiomics in oncology: current evidence, technical challenges, and future directions" Filippi, L., Bianconi, F., Marongiu, A. et al. rdcu.be/faM99 link.springer.com/article/10.100…

"Intratumoral metabolic heterogeneity, tumor stage, and biological complexity in nasopharyngeal carcinoma" Tekcan Sanli, D.E., Sanli, A.N. rdcu.be/faNfK link.springer.com/article/10.100…

"Radiolabelled FAPI PET imaging in the era of immunotherapy: potential role in predicting tumour response and prognosis, and detecting immune-related adverse events – a short review" Perrone, E., Taralli, S., Calcagni, M.L. et al. rdcu.be/faNjY